Back to search

Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer

NCT03661567

PHASE2INTERVENTIONAL
Sun Yat-sen University
52 participants
Started 2018-08-09 · Completed 2021-09-10
Status: Terminated (as of 12-23-2025)

Conditions

Non-small Cell Lung Cancer

Linked Papers (from SciSciNet-V2)

Total Papers16
Background
6
Result
0
Derived
0
Unknown
10

Total Citations Per Year

Brief Summary

This Phase II randomized controlled study is to determine the efficacy of the preventively use of methylprednisolone after split-course chemoradiotherapy (CCRT) in locally advanced non-small cell lung cancer with bulky tumor.

Sort by:

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked